Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of CGRP in Human Vestibulo-Ocular Reflex (VOR)
NCT07826910Phase 4Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atogepant in migraine (2 arms). Primary endpoint: Change in vestibulo-ocular reflex (VOR) gain measured by video head impulse test (vHIT). Planned start Jan 2027; status: not yet recruiting.
02
Drugs
atogepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07826910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826910.